ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives
ANI Pharmaceuticals to Present at Upcoming December Investor Conference
2026-11-19
ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results
2026-11-05
$69.05
-2.42 (-3.39%)
Pricing delayed by 20 minutes
Last updated
2026-11-19 15:43:00